Article ; Online: Knockdown of Hyaluronan synthase 2 suppresses liver fibrosis in mice via induction of transcriptomic changes similar to 4MU treatment.
2024 Volume 14, Issue 1, Page(s) 2797
Abstract: Hepatic fibrosis remains a significant clinical challenge due to ineffective treatments. 4-methylumbelliferone (4MU), a hyaluronic acid (HA) synthesis inhibitor, has proven safe in phase one clinical trials. In this study, we aimed to ameliorate liver ... ...
Abstract | Hepatic fibrosis remains a significant clinical challenge due to ineffective treatments. 4-methylumbelliferone (4MU), a hyaluronic acid (HA) synthesis inhibitor, has proven safe in phase one clinical trials. In this study, we aimed to ameliorate liver fibrosis by inhibiting HA synthesis. We compared two groups of mice with CCl |
---|---|
MeSH term(s) | Animals ; Mice ; Gene Expression Profiling ; Hyaluronan Synthases/genetics ; Hyaluronan Synthases/metabolism ; Hyaluronic Acid/metabolism ; Hymecromone/pharmacology ; Liver Cirrhosis/chemically induced ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/genetics ; RNA, Small Interfering |
Chemical Substances | Hyaluronan Synthases (EC 2.4.1.212) ; Hyaluronic Acid (9004-61-9) ; Hymecromone (3T5NG4Q468) ; RNA, Small Interfering ; Has2 protein, mouse (EC 2.4.1.212) |
Language | English |
Publishing date | 2024-02-02 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2615211-3 |
ISSN | 2045-2322 ; 2045-2322 |
ISSN (online) | 2045-2322 |
ISSN | 2045-2322 |
DOI | 10.1038/s41598-024-53089-x |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.